| Literature DB >> 23406680 |
Brad P Barnett1, James T Handa.
Abstract
BACKGROUND: Age-related macular degeneration (AMD) is the leading cause of blindness in the western world. To prevent what will certainly be a tremendous health and economic burden, effective therapeutics for AMD are urgently needed. To develop these agents in a timely fashion, the molecular pathways that cause disease progression must be elucidated.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23406680 PMCID: PMC3753825 DOI: 10.1159/000346169
Source DB: PubMed Journal: Gerontology ISSN: 0304-324X Impact factor: 5.140